[Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D008076:Cholesterol, HDL / Q000097:blood; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008055:Lipids / Q000097:blood*; D019829:Nevirapine / Q000009:adverse effects / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
D019380:Anti-HIV Agents; D008076:Cholesterol, HDL; D008055:Lipids; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine
Neue Daten sprechen für Nevirapin. Die antiretrovirale Wirkung stimmt--und auch das Lipidprofil.